Review Articles Concerning Pulmonary Vascular Disease

Clinical Presentations, Comorbidities, and Diagnostic Approaches in Sinus Venosus Atrial Septal Defect: A Literature Review

Dima Bsat, Dalia Safi, Jad Abdul Khalek, Issam El Rassi, Mariam ArabiAmerican University of Beirut Medical Center. Al Jalila Children’s Hospital.Lebanon and United Arab Emirates Cardiology in ReviewCardiol Rev 2026; DOI: 10.1097/CRD.0000000000001284 AbstractSinus venosus atrial septal defect is a rare congenital heart defect that is frequently associated with partial anomalous pulmonary venous return (PAPVR). This defect […]

Clinical Presentations, Comorbidities, and Diagnostic Approaches in Sinus Venosus Atrial Septal Defect: A Literature Review Read More »

The Right Ventricle, the Forgotten Chamber or Not

Ranjini Srinivasan, Alessandro Castiglione, Michael Antonchak, Ellen OstenfeldWeill Cornell School of Medicine. Lund University and Skåne University Hospital. New York University Grossman School of Medicine.United States and Sweden Magnetic Resonance Imaging Clinics of North AmericaMagn Reson Imaging Clin N Am 2026; 34: 217-230DOI: 10.1016/j.mric.2026.01.011 AbstractRight ventricular (RV) enlargement or dysfunction evaluation is the cornerstone for diagnosis, prognostications, and treatment planning in a variety

The Right Ventricle, the Forgotten Chamber or Not Read More »

Pediatric Pulmonary Vein Stenosis and Treatment

Joice Prodigios, Stephanie El Omeiri, Marcus Meneses, Bethelhem Belachew, Hansel J. Otero, David M. Biko, Jordan B. RappChildren’s Hospital of Philadelphia and Perelman School of Medicine at The University of Pennsylvania.United States Seminars in RoentenologySemin Roentenol 2025;DOI: 10.1053/j.ro.2025.09.006 AbstractPulmonary vein stenosis (PVS) is an uncommon but often progressive condition in children, associated with high morbidity and

Pediatric Pulmonary Vein Stenosis and Treatment Read More »

From standard to individualized diazoxide therapy in congenital hyperinsulinism: a narrative review

Teresa Wong, Daniel Chan, Cherie Chua, Wenqi Cher, Selina Lim, Suresh Chandran, Fabian YapKK Women’s and Children’s Hospital. Duke NUS Medical School. Singapore Frontiers in PharmacologyFront Pharmacol 2026; 17:DOI: 10.3389/fphar.2026.1781424 AbstractPurpose: Congenital hyperinsulinism (CHI) is the commonest cause of persistent hypoglycaemia in neonates and infants (blood glucose <3.0 mmol/L in first 2-3 days of life; <3.5 mmol/L

From standard to individualized diazoxide therapy in congenital hyperinsulinism: a narrative review Read More »

Hypertrophic Cardiomyopathy as a Key Feature of MRAS-Related Noonan Syndrome: New Case and Comprehensive Literature Review

Romain Martineau, Constance Wells, Florent Fuchs, Sophie Collardeau‐Frachon, Valentin Ruault, Sophie Colomb, Jean‐Michel Faure, Caroline Bartholmot, Marie Vincenti, Benjamin Ganne, Marjolaine WillemsUniversity Hospital of Montpellier and Montpellier University. CESP Center for Research in Epidemiology and Population Health. Hospices Civils de Lyon & Université Claude Bernard. France Prenatal DiagnosisPrenat Diagn 2026; DOI: 10.1002/pd.70134 AbstractNoonan syndrome (NS) is

Hypertrophic Cardiomyopathy as a Key Feature of MRAS-Related Noonan Syndrome: New Case and Comprehensive Literature Review Read More »

Emerging significance of E3 ubiquitin ligases and Deubiquitinases in pulmonary hypertension

Chao-Wei Ding, Jia-Yong Qiu, Hui Shen, Yi Yan, Ze-Xin Liu, Shen-Shen Huang, Yue-Jiao Ma, Zhi-Cheng JingXiamen Humanity Hospital of Fujian Medical University. Second Hospital of Hebei Medical University. Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences and Southern Medical University. First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and

Emerging significance of E3 ubiquitin ligases and Deubiquitinases in pulmonary hypertension Read More »

Congenital Heart Disease and Pulmonary Arterial Hypertension: Current Perspectives

Enrique Blanca-Jover, Francisco Contreras-Chova, Antonio Jerez-Calero, Jose Uberos-Fernandez, Laura Pérez-LaraUniversity of Granada and niversity Hospital of Granada.Spain Reviews in Cardiovascular MedicineRev Cardiovasc Med 2026; 27: DOI: 10.31083/RCM48337 AbstractPulmonary arterial hypertension (PAH) is the most serious complication of congenital heart disease (CHD), constituting a heterogeneous clinical entity classified within Group 1 of the Clinical Classification of Pulmonary

Congenital Heart Disease and Pulmonary Arterial Hypertension: Current Perspectives Read More »

Postnatal Steroids in Preterm Infants: A Narrative Review Series-Part 2: Cardiovascular Impacts

Phoenix Plessas-Azurduy, Anie Lapointe, Punnanee Wutthigate, Sarah Spénard, Andréanne Villeneuve, Audrey Hébert, Eilon Shany, Justin Richardson, Neta Geva, Wadi Mawad, Tiscar Cavallé-Garrido, Marc Beltempo, Wissam Shalish, Guilherme Sant’Anna, Gabriel AltMcGill University. Université de Montréal, CHU Sainte-Justine. Mahidol University. Montreal Children’s Hospital. CHU de Québec and Laval University. Saban Children’s Hospital and Soroka Medical Center. Ben

Postnatal Steroids in Preterm Infants: A Narrative Review Series-Part 2: Cardiovascular Impacts Read More »

An overview of the placenta’s role in the development of congenital diaphragmatic hernia

Nilhan Torlak, Marc Oria, Braxton Forde, Jose L. Peiro, Emrah AydinNew York University Grossman School of Medicine. Cincinnati Children’s Hospital Medical Center. University of Cincinnati College of Medicine. Koç University. University of Miami Miller School of Medicine.United States and Poland Frontiers in PediatricsFront Pediatr 2026; 14: DOI: 10.3389/fped.2026.1783068 AbstractCongenital diaphragmatic hernia (CDH) is a severe congenital

An overview of the placenta’s role in the development of congenital diaphragmatic hernia Read More »

Adventitial Niches, Complement and Inflammation in Pulmonary Vascular Disease: Current Status and Future Directions

Hui Zhang, Ram Raj Prasad, Sushil Kumar, Min Li, Dallas Jones, Cheng-Jun Hu, Claudia Mickael, Yen-Rei Yu, Rubin M. Tuder, Kurt R. StenmarkUniversity of Colorado Anschutz Medical Campus.United States Comprehensive PhysiologyCompre Physiol 2026; 16: DOI: 10.1002/cph4.70133 AbstractThere is strong evidence supporting inflammatory and autoimmune processes in the pathogenesis of pulmonary arterial hypertension (PAH), although the initiating

Adventitial Niches, Complement and Inflammation in Pulmonary Vascular Disease: Current Status and Future Directions Read More »

Scroll to Top